pH-Responsive Triplex DNA Nanoswitches: Surface Plasmon Resonance Platform for Bladder Cancer-Associated microRNAs
ACS Nano · 2025
DOI: 10.1021/acsnano.4c16396 ↗At a glance
Journal article in ACS Nano, 2025. Written by Pei-Ying Lin and 5 co-authors. Institution: Department of Biochemical Science and Technology, National Taiwan University, Taipei 10617, Taiwan. Major MEDLINE topics: MicroRNAs, Urinary Bladder Neoplasms, Surface Plasmon Resonance, DNA. Cited 30 times so far (Crossref); 82 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Science and Technology Council, Ministry of Education of Taiwan.
Abstract (original language)
Bladder cancer (BC) has a high recurrence rate, necessitating frequent monitoring. We herein present an innovative method for detecting BC-related miR-183 and miR-155 microRNAs using pH-responsive triplex DNA nanoswitches (TDNs). This approach employs a stepwise surface plasmon resonance biosensing platform (TDNs-SPR assay) to detect these two miRNAs sequentially. The platform involves the assembly of two triplex pH-responsive probes, switch A (SA) and switch B (SB), on an SPR sensing interface by anchoring the probes to the surface through SA/miR-183 and SB/miR-155 binding to the S9.6 antibody-modified surface. The probes are functionalized with streptavidin-Au nanoparticles/biotinylated strands, which act as reporter units for the presence of the respective miRNAs on the sensing interface. The pH-induced displacement of reporter units triggers stepwise SPR reflectivity changes: at pH 5.0 for sensing miR-183 and at pH 8.3 for sensing miR-155. The reflectivity changes relate quantitatively to the concentrations of miRNAs. This sensing platform enables the detection of two miRNAs with detection limits as low as 0.57 pM for miR-183 and 0.83 pM for miR-155, highlighting its powerful utility for precise biomarker analysis. Moreover, this platform distinguishes BC patients from healthy individuals in urine samples. The method offers a versatile, noninvasive method for detecting any two miRNAs associated with other diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biochemical Science and Technology, National Taiwan University, Taipei 10617, Taiwan.
- Artificial Intelligence Research Center, Chang Gung University, Taoyuan 33302, Taiwan.
- Department of Gastroenterology and Hepatology, New Taipei Municipal Tucheng Hospital (Built and Operated by Chang Gung Medical Foundation), New Taipei City 23652, Taiwan.
- Department of Urology, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
- Department of Medicine and Nursing, HungKuang University, Taichung 43304, Taiwan.
- Organic Electronics Research Center, Ming Chi University of Technology, New Taipei City 243303, Taiwan.
ORCID profiles: Cheng-Che Chen, Ja-An Annie Ho
Funding
- National Science and Technology Council
- Ministry of Education of Taiwan
Cite
APA
Lin, P. Y., Chang, Y. F., Chen, C. C., Su, L. C., Willner, I., & Ho, J. A. (2025). pH-Responsive Triplex DNA Nanoswitches: Surface Plasmon Resonance Platform for Bladder Cancer-Associated microRNAs. ACS Nano. https://doi.org/10.1021/acsnano.4c16396
Vancouver
Lin PY, Chang YF, Chen CC, Su LC, Willner I, Ho JA. pH-Responsive Triplex DNA Nanoswitches: Surface Plasmon Resonance Platform for Bladder Cancer-Associated microRNAs. ACS Nano. 2025. doi:10.1021/acsnano.4c16396
BibTeX
@article{Lin2025,
author = {Lin, Pei-Ying and Chang, Ying-Feng and Chen, Cheng-Che and Su, Li-Chen and Willner, Itamar and Ho, Ja-An Annie},
title = {pH-Responsive Triplex DNA Nanoswitches: Surface Plasmon Resonance Platform for Bladder Cancer-Associated microRNAs},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.4c16396}
}
EUVIMED